Back to search results

18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Esophageal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Steven Lin, MD) · shlin@mdanderson.org · 713-563-8490
    Contact: Principal Investigator (Steven Lin, MD)
Study leads

  • Steven Lin, MD

    Principal Investigator

    M.D. Anderson Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)